Amyn M Rojiani
Overview
Explore the profile of Amyn M Rojiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1355
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rojiani M, Rojiani A
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398107
Lung cancer is one of the leading causes of cancer-related mortality worldwide among men and women [...].
2.
Lipscomb M, Joste N, Markwood M, Bailey D, Hansel D, Jorda M, et al.
Acad Pathol
. 2023 May;
10(2):100082.
PMID: 37168284
Females are under-represented as departmental chairs in academic medical centers and identifying ways to increase their numbers in this position would be useful. A previous study of women chairs of...
3.
George M, Markwood M, Rojiani A
Acad Pathol
. 2023 Mar;
10(1):100061.
PMID: 36970327
Academic pathology departments across the United States vary greatly in terms of size, clinical workloads and research activity. It is therefore not surprising that their chairs may be an equally...
4.
Xiao W, Ahluwalia P, Wang L, Howard J, Kolhe R, Rojiani A, et al.
Cells
. 2022 Oct;
11(19).
PMID: 36230997
The development of chemoresistance remains a significant barrier to treating NSCLC. Alteration of cancer cell metabolism is an important mechanism for chemoresistance. This study explored the role of aberrant metabolism...
5.
Sahajpal N, Mondal A, Ananth S, Njau A, Jones K, Ahluwalia P, et al.
Sci Rep
. 2022 Mar;
12(1):3480.
PMID: 35241679
The COVID-19 pandemic has resulted in significant diversion of human and material resources to COVID-19 diagnostics, to the extent that influenza viruses and co-infection in COVID-19 patients remains undocumented and...
6.
Ahluwalia P, Mondal A, Ahluwalia M, Sahajpal N, Jones K, Jilani Y, et al.
Cancer Med
. 2022 Feb;
11(6):1573-1586.
PMID: 35137551
Understanding the complex tumor microenvironment is key to the development of personalized therapies for the treatment of cancer including colorectal cancer (CRC). In the past decade, significant advances in the...
7.
Sahajpal N, Jill Lai C, Hastie A, Mondal A, Dehkordi S, van der Made C, et al.
iScience
. 2022 Jan;
25(2):103760.
PMID: 35036860
Impressive global efforts have identified both rare and common gene variants associated with severe COVID-19 using sequencing technologies. However, these studies lack the sensitivity to accurately detect several classes of...
8.
Kolhe R, Sahajpal N, Vyavahare S, Dhanani A, Adusumilli S, Ananth S, et al.
Diagnostics (Basel)
. 2021 Sep;
11(9).
PMID: 34573964
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is an infectious virus that causes coronavirus disease 2019 (COVID-19) transmitted mainly through droplets and aerosol affecting the respiratory tract and lungs. Little...
9.
John G, Sahajpal N, Mondal A, Ananth S, Williams C, Chaubey A, et al.
Curr Issues Mol Biol
. 2021 Aug;
43(2):845-867.
PMID: 34449545
This review discusses the current testing methodologies for COVID-19 diagnosis and explores next-generation sequencing (NGS) technology for the detection of SARS-CoV-2 and monitoring phylogenetic evolution in the current COVID-19 pandemic....
10.
Sahajpal N, Mondal A, Ananth S, Njau A, Fulzele S, Ahaluwalia P, et al.
Acad Pathol
. 2021 Jul;
8:23742895211023948.
PMID: 34263025
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, led to unprecedented demands assigned to clinical diagnostic laboratories worldwide, forcing them to make significant changes to their regular...